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Our paper presented a new algorithm, named PreCISE, designed to identify synergistic drug interactions that are effective at killing
cancer cells harboring specific driver mutations. Using this platform and a cell-line-based screen, we identified a synergistic drug
interaction between Chk1- and MK2 inhibitors in KRAS- or BRAF-driven cells, and that combination of therapy focused on these
two kinase inhibitors is effective at inducing cell death of KRAS- and BRAF mutant tumors in vivo.
While reviewing the paper after publication, we noticed that we had included two erroneous duplications of western blot loading con-
trol bands in the final version of Figure 2E. This figure shows that simultaneous inhibition of Chk1 and MK2 induces genotoxic stress
and apoptosis in several KRAS-driven cancer cell lines and respective controls. The incorrect loading controls are presented for the
HSP27 blot for the H1703 cell line, as well as for the CDC25B blot for the H1437 cell line. The errors occurred when we were copying
each blot to construct the final figure. We recovered the original autoradiographs of these experiments and now provide a new
version of the figure containing the correct loading controls. The correct data supports the original interpretation of the experiment,
and the conclusions of the paper remain unchanged. In addition, we observed a typo in Figure S3A, showing the distribution of all cell
lines used in the initial screen of our paper. In the pie chart, the slice of the pie in purple representing ‘‘lung squamous’’ cell lines was
incorrectly labeled with n = 18. The correct value is n = 3, as depicted in the figure legend and in the main text. Both figures are now
corrected online. We regret not being able to identify these errors before and sincerely apologize for any inconvenience they may
have caused.Cell 162, 1169, August 27, 2015 ª2015 Elsevier Inc. 1169
